Home | Medical Breakthroughs | Leaving home: Beta cells' way to maturity

Leaving home: Beta cells' way to maturity

Beta Cells

Professor Henrik Semb and his group at the Danish Stem Cell Center have gained new insight into the molecular mechanism behind new born beta cells’ way to maturity. In depth knowledge about beta cell maturation is one of the fundamental ingredients in the development of future stem cell-based therapies in Diabetes as only correct and complete maturation will provide us with fully functional, glucose-responsive and insulin producing cells.

Beta cells are born in the developing pancreatic tubular epithelium, which gives rise to all endocrine and exocrine cells of the mature pancreas. Professor Semb and his team showed that the new born beta cells’ exiting and physical movement from their birth place within the epithelial tubes coincides with, but are independent of their maturation. “Our studies show that both the exiting and the maturation are regulated by the same signalling pathway called Cdc42/N-WASP, but very interestingly, we also found that the two important events occur independent of one another,” explains Henrik Semb.

New-born beta cells in the pancreatic epithelial layer.

New-born beta cells in the pancreatic epithelial layer

The actual exiting comes about through a loosening of the adhesion between newly born beta cells and their neighbours. The cells are thereby released from the integrated epithelial layer, paving the way for their journey towards maturity. Concomitant with the exiting towards a life as part of the islets of Langerhans, Professor Semb and his team also show for the first time that mechanical forces within the cell - via the cytoskeleton – directly regulates maturation via specific gene expression changes.

“This new insight into the beta cell maturation process provides an important missing link in the efforts to generate fully functional, glucose-responsive and insulin producing cells from stem cells. Our long-term goal is to generate mature and fully functional beta cells which can be used in future stem cell-based therapies in Diabetes,” says Henrik Semb.

The result is published online on January 21, 2014 in the scientific journal Development in the article: Cdc42/N-WASP signaling links actin dynamics to pancreatic beta cell delamination and differentiation

Contact: Professor Henrik Semb, semb@sund.ku.dk or Research Coordinator Johanne Keiding, johanne.keiding@sund.ku.dk, +45 20 56 00 63

Subscribe to comments feed Comments (0 posted)

total: | displaying:

Post your comment

  • Bold
  • Italic
  • Underline
  • Quote

Please enter the code you see in the image:

Captcha
  • Email to a friend Email to a friend
  • Print version Print version
  • Plain text Plain text

Tagged as:

No tags for this article

Rate this article

0